Literature DB >> 5953092

Patient protection in cancer chemotherapy.

S A Schwartz, S Perry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5953092

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results.

Authors:  M Dietrich; W Gaus; J Vossen; D van der Waaij; F Wendt
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  [Clinical gnotobiotics in hematology].

Authors:  M Dietrich
Journal:  Blut       Date:  1974-05

3.  Oral dose and faecal concentration of antibiotics during antibiotic decontamination in mice and in a patient.

Authors:  D van der Waaij; J M Berghuis-de Vries; C Korthals Altes
Journal:  J Hyg (Lond)       Date:  1974-10

4.  Care and observation of a germ-free neonate.

Authors:  R D Barnes; A Bentovim; S Hensman; A T Piesowicz
Journal:  Arch Dis Child       Date:  1969-04       Impact factor: 3.791

5.  Ozone decontamination of bioclean rooms.

Authors:  T Masaoka; Y Kubota; S Namiuchi; T Takubo; T Ueda; H Shibata; H Nakamura; J Yoshitake; T Yamayoshi; H Doi; T Kamiki
Journal:  Appl Environ Microbiol       Date:  1982-03       Impact factor: 4.792

6.  Medical applications of dust-free rooms. I. Elimination of airborne bacteria in a research laboratory.

Authors:  L L Coriell; G J McGarrity; J Horneff
Journal:  Am J Public Health Nations Health       Date:  1967-10

7.  Microbiological evaluation of protected environments during patient occupancy.

Authors:  G P Bodey; D Johnston
Journal:  Appl Microbiol       Date:  1971-11

8.  Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora.

Authors:  G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  Oropharyngeal cultures of patients in protected environment units: evaluation of semiquantitative technique during antibiotic prophylaxis.

Authors:  D A Johnston; G P Bodey
Journal:  Appl Microbiol       Date:  1972-05

10.  Clinical use of reverse isolation in a protected environment.

Authors:  M Bláha; J Vanásek; V Mĕrka; M Splino; J Malý; O Siroký
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.